xylose has been researched along with Diabetes Mellitus, Type 2 in 13 studies
*Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Alpert, E; Ben Yakir, M; Cerasi, E; Cohen, G; Elgart, A; Gruzman, A; Hoffman, A; Katzhendler, Y; Sandovski, D; Sasson, S; Shamni, O | 1 |
| Bohlmann, J; Irmisch, S; Jancsik, S; Madilao, LL; Yuen, MMS | 1 |
| Al-Harrasi, A; Behl, T; Bhatia, S; Bungau, S; Diaconu, CC; Gupta, A; Hafeez, A; Rahdar, A; Sehgal, A; Sharma, N; Sharma, S; Singh, S | 1 |
| Caiazzo, R; D'Herbomez, M; Gmyr, V; Hubert, T; Pattou, F; Pigny, P; Tréchot, B; Verhaeghe, R; Zerrweck, C | 1 |
| Almstead, ZY; Bardenhagen, J; Buhring, LM; DaCosta, CM; Goodwin, NC; Harrison, BA; Healy, J; Kimball, SD; Liu, Q; Mabon, R; Mseeh, F; Nouraldeen, A; Powell, DR; Rawlins, DB; Shadoan, MK; Wilson, AG; Xie, Y | 1 |
| Aulinger, B; D'Alessio, DA; Prigeon, RL; Salehi, M | 1 |
| Chang, CC; Chao, YS; Chen, CT; Chiu, CH; Chu, KF; Hsiao, WC; Hsieh, CJ; Hsieh, TC; Huang, CY; Hung, MS; Lee, JC; Liu, YW; Song, JS; Tsai, CH; Wang, MH; Wu, SH; Yao, CH; Yeh, TK; Yuan, MC | 1 |
| Bellon, M; Bound, MJ; Horowitz, M; Jones, KL; Rayner, CK; Standfield, SD; Wu, T; Zhao, BR | 1 |
| Parsons, SR | 1 |
| Adamson, U; Kollind, M; Lins, PE; Ohlsén, P | 1 |
| Bhardwaj, PK; Dasgupta, DJ; Kaushal, SS; Prashar, BS | 1 |
| Fujimiya, M; Fujita, Y; Hidaka, H; Kashiwagi, A; Kikkawa, R; Kojima, H | 1 |
| Adamson, U; Kollind, M; Lins, PE | 1 |
1 review(s) available for xylose and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
A spotlight on underlying the mechanism of AMPK in diabetes complications.
Topics: AMP-Activated Protein Kinases; Animals; Berberine; Diabetes Complications; Diabetes Mellitus, Type 2; Enzyme Activation; Gene Expression Regulation, Enzymologic; Glucose; Homeostasis; Humans; Insulin Resistance; Lipid Metabolism; Mice; Phosphorylation; Polyphenols; Protein Conformation; Protein Domains; Rats; Thiazolidinediones; Thioctic Acid; Xylose | 2021 |
4 trial(s) available for xylose and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetes.
Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Enzyme-Linked Immunosorbent Assay; Female; Gastric Emptying; Glucagon-Like Peptide 1; Humans; Insulin; Male; Middle Aged; Postprandial Period; Pyrazines; Radioimmunoassay; Sitagliptin Phosphate; Triazoles; Xylose | 2013 |
Effects of high fiber breakfasts on glucose metabolism in noninsulin-dependent diabetics.
Topics: Absorption; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Diet; Dietary Fiber; Edible Grain; Female; Fruit; Glucagon; Growth Hormone; Humans; Insulin; Male; Middle Aged; Xylose | 1984 |
Extrapancreatic effects of a sulphonylurea. Decrease in xylose absorption by glipizide in type II diabetics.
Topics: Administration, Oral; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Female; Glipizide; Glucose Tolerance Test; Humans; Injections, Intravenous; Insulin; Insulin Secretion; Male; Middle Aged; Sulfonylurea Compounds; Xylose | 1984 |
Glipizide does not affect absorption of glucose and xylose in diabetics without residual beta-cell function.
Topics: Adult; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glipizide; Glucose Tolerance Test; Humans; Intestinal Absorption; Islets of Langerhans; Sulfonylurea Compounds; Xylose | 1986 |
8 other study(ies) available for xylose and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Novel D-xylose derivatives stimulate muscle glucose uptake by activating AMP-activated protein kinase alpha.
Topics: AMP-Activated Protein Kinases; Animals; Diabetes Mellitus, Type 2; Drug Design; Enzyme Activation; Glucose; Glucose Transporter Type 4; Humans; Models, Biological; Models, Chemical; Muscles; Rats; Structure-Activity Relationship; Xylose | 2008 |
Biosynthesis of the anti-diabetic metabolite montbretin A: glucosylation of the central intermediate mini-MbA.
Topics: Caffeic Acids; Diabetes Mellitus, Type 2; Flavones; Flavonoids; Flavonols; Gene Expression Profiling; Gene Expression Regulation, Plant; Glucose; Glucosyltransferases; Glycosides; Glycosylation; Hypoglycemic Agents; Iridaceae; Metabolic Engineering; Nicotiana; Phylogeny; Plant Proteins; Plant Stems; Plants, Genetically Modified; Rhamnose; Secondary Metabolism; Synthetic Biology; Transcriptome; Trisaccharides; Xylose | 2019 |
Gastric bypass increases postprandial insulin and GLP-1 in nonobese minipigs.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Glucagon-Like Peptide 1; Humans; Insulin; Models, Anatomic; Models, Animal; Obesity; Postprandial Period; Swine; Swine, Miniature; Xylose | 2014 |
Novel L-xylose derivatives as selective sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Drug Discovery; Glucose; Humans; Mice; Sodium-Glucose Transporter 2 Inhibitors; Substrate Specificity; Xylose | 2009 |
Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes.
Topics: Adult; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Female; Glucagon-Like Peptide 1; Glucose; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Middle Aged; Postprandial Period; Reference Values; Xylose | 2010 |
Discovery of novel N-β-D-xylosylindole derivatives as sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the management of hyperglycemia in diabetes.
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Glucosides; Humans; Hyperglycemia; Hypoglycemic Agents; Indoles; Male; Mice; Mice, Inbred ICR; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors; Structure-Activity Relationship; Xylose | 2011 |
Control of hyperglycaemia and hyperlipidaemia by plant product.
Topics: Absorption; Blood Glucose; Case-Control Studies; Cholesterol; Cholesterol, LDL; Diabetes Mellitus, Type 2; Drug Combinations; Female; Follow-Up Studies; Galactans; Glucose Tolerance Test; Humans; Hyperglycemia; Hyperlipidemias; Male; Mannans; Middle Aged; Plant Extracts; Plant Gums; Plants, Medicinal; Trigonella; Xylose | 1994 |
Increased intestinal glucose absorption and postprandial hyperglycaemia at the early step of glucose intolerance in Otsuka Long-Evans Tokushima Fatty rats.
Topics: Animals; Diabetes Mellitus; Diabetes Mellitus, Type 2; Food; Gene Expression; Glucose; Glucose Intolerance; Glucose Tolerance Test; Hyperglycemia; Insulin Resistance; Intestinal Absorption; Intestines; Male; Monosaccharide Transport Proteins; Obesity; Phlorhizin; Rats; Rats, Long-Evans; Xylose | 1998 |